Programming – Vascular Discovery 2024
May 15–18, 2024
Hilton Chicago | Chicago, Illinois
Vascular Discovery 2024 Schedule-at-a-Glance
All times are Central Daylight Time (CDT, GMT -5)
Time | Activity |
---|---|
8:00 a.m. – 6:00 p.m. | Vascular Research Initiatives Conference(link opens in new window) This event is not part of the official Vascular Discovery Scientific Sessions as planned by the Program Committee. Separate registration is required to attend. |
3:00 p.m. – 7:00 p.m. | Vascular Discovery Scientific Sessions Registration |
6:30 p.m. – 8:00 p.m. | Poster Session 1 & Reception |
Time | Activity |
---|---|
7:00 a.m. to 8:00 a.m. | Registration, Breakfast, Exhibits |
7:00 a.m. to 8:00 a.m. | Early Career Training Session 1 – Academic Roundtables 7:00 - Getting Your Training Grant Funded 7:00 - Saying No and Difficult Conversations 7:00 - Setting Up Your Lab, Hiring and Switching Universities 7:00 - The Importance of Mentoring and Being Mentored 7:00 - Work-Life Balance 7:00 - Strategies for Project Management |
8:00 a.m. to 8:30 a.m. |
Conference Opening Welcome 8:00 Welcome Remarks from AHA President 8:15 Welcome Remarks from the Program Chair |
8:30 a.m. to 10:00 a.m. |
Plenary Session 1: Hot Topics in Cardiovascular Disease 8:30 Complementing Human Organoids for Vascular Discovery 9:00 Clonal hematopoiesis, aging, and CVD 9:30 Title TBA |
10:00 a.m. to 10:30 a.m. | BREAK/Exhibits |
10:30 a.m. to 12:15 p.m. |
Concurrent Session 1a: Molecular and Cellular Mechanisms of Atherosclerosis 10:30 Title TBA 11:00 Oral Abstract Presentations |
10:30 a.m. to 12:15 p.m. |
Concurrent Session 1b: Inflammation & Immunity in the Vessel Wall 10:30 Macrophages in Aortic Aneuysm 11:00 Oral Abstract Presentations |
10:30 a.m. to 12:15 p.m. |
Concurrent Session 1c: Endothelial Dysfunction in Thrombosis 10:30 Regulation of Endothelial Procoagulant Activity by TMEM16 Proteins 10:50 Genetic analysis of endothelial protease-activated receptors in disease contexts 11:10 Presentation Title: TBD 11:30 Oral Abstract Presentations |
12:15 p.m. to 2:00 p.m. | The Mentor of Women Award Luncheon - Presented by the ATVB Women's Leadership Committee (ticket required) 12:15 - Networking 12:30 - Thriving as Internationally Trained Scholars
1:10 - Round Table Discussions
1:50 - Networking or or |
2:15 p.m. to 3:45 p.m. | Plenary Session 2: Highlights from the ATVB Journal 2:15 - ATVB Journal Update 2:30 - Daniel Steinberg Early Career Investigator Award in Atherosclerosis/Lipoproteins: Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis 2:45 - Karl Link Early Career Investigator Award in Thrombosis: Antithrombin, Protein C, and Protein S: Genome and Transcriptome-Wide Association Studies Identify 7 Novel Loci Regulating Plasma Levels Gut Bacterial Metabolism and Cardiometabolic Disease 3:00 - Werner Risau Early Career Investigator Award in Vascular Biology: Dedifferentiation and Proliferation of Artery Endothelial Cells Drive Coronary Collateral Development in Mice 3:15 - Presentation Title: TBA |
3:45 p.m. to 4:15 p.m. | Break/Exhibits |
4:15 p.m. to 6:00 p.m. |
Concurrent Session 2a: Apolipoproteins, Lipoproteins, and Lipid Metabolism 4:15 Massively Parallel Interrogation of Lipoprotein Uptake Modifiers |
4:15 p.m. to 6:00 p.m. |
Concurrent Session 2b: Thrombosis: Signaling, Mechanisms and Function 4:15 Targeting Neutrophils in Immunothrombosis 4:45 Oral Abstract Presentations |
4:15 p.m. to 6:00 p.m. |
Concurrent Session 2c: Investigator in Training Award Oral Abstract Competition |
6:00 p.m to 7:30 p.m. |
Poster Session 2 & Reception |
Time | Activity |
---|---|
7:00 a.m. | Registration, Breakfast & Exhibits |
7:00 a.m. to 8:00 a.m. | Early Career Training Session 2 – Academic Success Stories (Panel Discussion) 7:00 - Panel Discussants |
8:00 a.m. to 9:30 a.m. |
Plenary Session 3: Advances in Cardiometabolic Disease 8:00 Presentation title TBA 8:30 16 Years of GWAS - From a Single Locus to 393 Genome-wide Significant CAD Associations 9:00 Gut Bacterial Metabolism and Cardiometabolic Disease |
9:30 a.m. to 10:00 a.m. | BREAK/Exhibits |
10:00 a.m. to 11:45 a.m. |
Concurrent Session 3a: Therapeutic Targets in Atherosclerosis 10:00 Enhanced endothelial cell retention within tissue engineered vascular grafts 10:30 Oral Abstract Presentations |
10:00 a.m. to 11:45 a.m. |
Concurrent Session 3b: Blood Coagulation in Health & Disease 10:00 Presentation title TBA 10:30 Oral Abstract Presentations |
10:00 a.m. to 11:45 a.m. |
Concurrent Session 3c: Carotid Artery Disease 10:00 Presentation title TBA 10:20 Presentation title TBA 10:40 Exploring Carotid Plaque Instability: a BIKE-ride from Identification of Molecular Disease Targets to Improved Stroke-risk Prediction 11:00 Endothelial Dysfunction in Carotid Atherothrombosis and Stroke 11:20 Oral Abstract Presentations |
11:45 a.m. to 1:45 p.m. | ATVB Diversity Committee Luncheon: Diversity and inclusion in the workplace: institutional support and legislative changes |
12:45 a.m. to 1:45 p.m. | Lunch on your own |
1:45 p.m. to 3:45 p.m. | Plenary Session 4: Early Career Investigator Award Competition: Brinkhous Prize and Page Jr Faculty Research Award |
3:45 p.m. to 4:15 p.m. | Break/Exhibits |
4:15 p.m to 6:00 p.m. |
Concurrent Session 4a: Metabolic Disorders in Atherosclerosis - Organized in cooperation with the Chinese International Congress of Vascular Medicine 4:15 Unlocking the Potential of Microbial-Host-Isozyme for Precision Treatment of Metabolic Diseases 4:45 Comprehensive Management of Metaboic Vascular Disease - 20 Years Vascular Health Promotion in China 5:15 Deubiquitinase BRCC3 Orchestra Metabolic Remodeling in Cardiovascular Disease 5:30 Prevention of Cardiovascular Disease: the Traditional Chinese Medicine Strategy 5:45 Oral Abstract Presentations |
4:15 p.m to 6:00 p.m. |
Concurrent Session 4b: Vascular Cells, Inflammation and Thrombosis 4:15 Cardiovascular Calcification 4:45 Oral Abstract Presentations |
4:15 p.m to 6:00 p.m. |
Concurrent Session 4c: Genomics and Multi-Omics in Vascular Disease 4:15 Presentation Title TBA 4:45 Presentation title TBA 5:15 Oral Abstract Presentations |
6:00 p.m. to 7:30 p.m. |
Poster Session 3 and Reception |
7:30 p.m. to 10:00 p.m. |
Joint Council Dinner
|
Time | Activity |
---|---|
7:00 a.m. to 12:00 p.m. | Registration |
7:00 a.m. to 8:30 a.m. | Continental Breakfast |
8:30 a.m. to 10:00 a.m. |
Plenary Session 5: Cardio-oncology: The Role of the Vasculature 8:30 Cardio-oncology Through a Vascular Lens 9:00 Racial Disparites in Cardio-oncology - Defining Differences in Endothelial Function in Reponse to Anti-Cancer Therapy 9:30 Presentation title TBA 9:45 Oral Abstract Presentations |
10:00 a.m. to 10:15 a.m. | BREAK/Exhibits |
10:15 a.m. to 12:15 p.m. |
Plenary Session 6: Invited Lecture Series 10:15 Hoeg Award Lecture 10:45 Keynote Lecture 11:15 Distinguished Lecture: Targets for New Anticoagulants: XI Before XII 11:45 PVD Mid-Career Award Lecture |
12:15 p.m. | Closing Remarks / Adjourn |
Keynote Lecture and Distinguished Lecture Speakers
Kristy Red-Horse, PhD
Invited Lecture Series
Presentation Title: TBD
Kristy Red-Horse is a Professor at Stanford University’s Department of Biology and Institute for Stem Cell Biology & Regenerative Medicine. She is also an Investigator with the Howard Hughes Medical Institute. Her PhD research explored how the vasculature of the placenta incorporates within the uterine arterial network. As a postdoc at Stanford, Dr. Red-Horse identified the progenitors of coronary arteries in mouse hearts. In her own lab, she and her team went on to explore many different aspects of how coronary arteries develop from these progenitors. The Red-Horse group also studies how coronaries regenerate and respond to injury, and devises methods for increasing their growth to enhance cardiac recovery. Dr. Red-Horse has received awards such as the NIH Pathway to Independence Award (K99/R00) and the Searle Scholar’s Award. She was also a New York Stem Cell Foundation—Robertson Investigator and received the Judah Folkman Award in vascular biology. In 2021, Dr. Red-Horse was named a Howard Hughes Investigator. In 2023, Dr. Red-Horse became a member of the National Academy of Medicine.
Jeffrey Weitz, MD, FAHA, FRCPC, FRSC, FACP
Invited Lecture Series
Presentation Title: Targets for new anticoagulants: XI before XII
Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Executive Director of the Thrombosis and Atherosclerosis Research Institute and Past President of Council for the International Society on Thrombosis and Haemostasis. Board Certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Weitz focuses his clinical practice on patients with thrombotic disorders. His research spans the spectrum from basic studies in the biochemistry of blood coagulation and fibrinolysis to animal models of thrombosis and on to clinical trials of antithrombotic therapy. The breadth of his work is highlighted by his over 640 publications in journals as diverse as the Journal of Clinical Investigation, Journal of Biological Chemistry, Biochemistry, Circulation, Blood, Annals of Internal Medicine, New England Journal of Medicine and Lancet, and 76 book chapters. The recipient of numerous awards, Dr. Weitz was appointed as an Officer of the Order of Canada and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.
Vascular Discovery 2024
Invited Speakers
Carl Ade, PhD
Session: Cardio-oncology: the Role of the VasculaturePresentation Title: TBD
Zoltan Arany, MD, PhD
Session: Advances in Cardiometabolic DiseasePresentation Title: TBD
Andreas Beyer, PhD
Session: Cardio-oncology – The Role of the VasculaturePresentation Title: Racial disparities in cardio-oncolgy – Defining Differences in Endothelial Function in Response to Anti-Cancer Therapy
Zachary Clayton, PhD
Session: Cardio-oncology: the Role of the VasculaturePresentation Title: Anthracycline chemotherapy-mediated vascular dysfunction: Understanding basic mechanisms to inform future clinical therapies
Nirav Dhanesha, PhD
Session: Blood Coagulation in Health and DiseasePresentation Title: TBA
Brian Emmer MD, PhD
Session: Apolipoproteins, Lipoproteins and Lipid MetabolismPresentation Title: Massively Parallel Interrogation of Lipoprotein Uptake Modifiers
Santhi Ganesh, MD
Session: Carotid Artery DiseasePresentation Title: TBD
Chiara Giannareli, MD, PhD
Session: Inflammation and Immunity in the Vessel WallPresentation Title: TBD
Courney Griffin, PhD
Session: Endothelial Dysfunction in ThrombosisPresentation Title: Genetic analysis of endothelial protease-activated receptors in disease contexts
Kaizheng Gong, MD, PhD
Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular MedicinePresentation Title: Deubiquitinase BRCC3 Orchestra Metabolic Remodeling in Cardiovascular Disease
Ulf Hedin, MD, PhD
Session: Carotid Artery DiseasePresentation Title: Exploring carotid plaque instability: a BiKE-ride from identification of molecular disease targets to improved stroke-risk prediction
Kathryn L Howe MD, PhD, FRCSC
Session: Carotid Artery DiseasePresentation Title: Endothelial Dysfunction in Carotid Atherothrombosis and Stroke
Iris Jaffe, MD, PhD
Session: Cardio-oncology the Role of the VasculaturePresentation Title: Cardio-oncology Through a Vascular Lens
Changtao Jiang, MD, PhD
Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular MedicinePresentation Title: Unlocking the Potential of Microbial-Host-Isozyme for Precision Treatment of Metabolic Diseases
Minna Kaikkonen, PhD
Session: Hot Topics in Cardiovascular DiseasePresentation Title: TBD
Bo Liu, PhD
Session: Inflammation & Immunity in the Vessel WallPresentation Title: Macrophages in Aortic Aneurysm
Ruth McPherson, MD, PhD, FRCPC
Session: Advances in Cardiometabolic DiseasePresentation Title: 16 years of GWAS – From a Single Locus to 393 Genome-wide Significant CAD Associations
Clint Miller, PhD
Session: Genomics and Multi-Omics in Vascular DiseasePresentation Title: TBD
Lalitha Nayak, MD
Session: Thrombosis, Signaling Mechanisms, & FunctionPresentation Title: Targeting Neutrophils in Immunothrombosis
Hasina Outtz Reed, MD, PhD
Session: Endothelial Dysfunction in ThrombosisPresentation Title: TBD
Muredach Reilly, MD
Session: Molecular and Cellular Mechanisms of AtherosclerosisPresentation Title: TBD
Federico E. Rey, PhD
Session: Advances in Cardiometabolic DiseasePresentation Title: Gut Bacterial Metabolism and Cardiometabolic Disease
Alec A. Schmaier, MD, PhD
Session: Endothelial Dysfunction in ThrombosisPresentation Title: Regulation of endothelial procoagulant activity by TMEM16 proteins
Cynthia St. Hilaire, PhD, FAHA
Session: Vascular Cells, Inflammation and ThrombosisPresentation Title: Cardiovascular Calcification
Takanori, Takebe, MD, PhD
Session: Hot Topics in Cardiovascular DiseasePresentation Title: Complementing Human Organoids for Vascular Discovery
Catherine Tcheandjieu, DVM, PhD
Session: Genomics and Multi-Omics in Vascular DiseasePresentation Title: TBD
Brandon Tefft, PhD
Session: Therapeutic Targets in AtherosclerosisPresentation Title: Enhanced endothelial cell retention within tissue engineered vascular grafts
Kenneth Walsh, PhD
Session: Hot Topics in Cardiovascular DiseasePresentation Title: Clonal Hematopoiesis, Aging, and CVD
Hongyu Wang, MD, PhD
Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular MedicinePresentation Title: Comprehensive Management of Metabolic Vascular Disease: 20 Years Vascular Health Promotion in China
Chaoping Yu, MD
Session: Metabolic Disorders in AtherosclerosisPresentation Title: Prevention of Cardiovascular Disease: the Traditional Chinese Medicine Strategy
Wei Zhou, MD
Session: Carotid Artery DiseasePresentation Title: TBD
About this Meeting
This 2 ½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery's Vascular Research Initiatives Conference.
Vascular Discovery 2024 will provide unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise for the timely exchange of information about new and emerging scientific research in the areas of arteriosclerosis, thrombosis and vascular biology, peripheral vascular disease, vascular surgery research, genomics and precision medicine. We expect a broad representation from many disciplines and encourage young scientists to attend.
See the American Heart Association Policies and Guiding Values (PDF).
Target Audience
The conference will especially appeal to scientists and clinicians interested in:
- Allergy and Immunology
- Arteriosclerosis
- Biochemistry
- Biological Sciences
- Diabetes and Metabolism
- Functional Genomics
- Genetics
- Hematology
- Internal Medicine
- Molecular/Cellular Biology
- Nutrition
- Pathology
- Peripheral Artery Disease
- Pharmacology
- Physiology
- Vascular Surgery
- Thrombosis
- Vascular Biology
- Vascular Medicine
Learning Objectives
At the conclusion of this conference, participants will be able to:
- Discuss recent advances and emerging experimental models in ATVB and peripheral vascular diseases that target primary acquired diseases and/or secondary factors contributing to vascular-related disorders.
- Summarize findings from recent translational research or clinical trials and the impact for future treatment and/or management of vascular-related disorders.
- Describe best practices associated with ATVB scientific research and/or the management of patients with vascular-related diseases.